Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.
Press releases published on June 24, 2025
CovertNest Launches AI-Powered Real Estate Platform to Help International Professionals and First-Time Investors Build Rental Portfolios
GlobeNewswire
·
June 24, 2025
San Francisco, CA, June 24, 2025 (GLOBE NEWSWIRE) -- CovertNest today announced the launch of its AI-powered real estate investment platform, designed to help international professionals, first-generation immigrants, and full-time employees build wealth …
Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
GlobeNewswire
·
June 24, 2025
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
GlobeNewswire
·
June 24, 2025
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …
Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …
Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina
GlobeNewswire
·
June 24, 2025
DURHAM, Carolina del Norte, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (la "Empresa"), una organización líder mundial en investigación por contrato (CRO), anunció hoy una colaboración estratégica con Emery Pharma, una CRO analítica y …
Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA
GlobeNewswire
·
June 24, 2025
דורהאם, קרוליינה הצפונית, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (נאסד"ק:FTRE) ("החברה"), חברה שהיא ארגון מחקר מבוסס חוזים (CRO) גלובלית מובילה, הודיעה היום על שיתוף פעולה אסטרטגי עם Emery Pharma, חברת CRO אנליטית וביו-אנליטית מובילה המספקת שירותי בדיקה …
Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan kerjasama strategik dengan Emery Pharma, sebuah CRO analitik dan bioanalitik terkemuka …
Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA
GlobeNewswire
·
June 24, 2025
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje uma colaboração estratégica com a Emery Pharma, uma CRO analítica e bioanalítica líder que …
フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表
GlobeNewswire
·
June 24, 2025
ノースカロライナ州ダーラム発, June 24, 2025 (GLOBE NEWSWIRE) -- グローバルな大手医薬品開発業務受託機関 (CRO) であるフォートリア (NASDAQ: FTRE)(以下「同社」) は本日、大手分析・バイオ分析CROとしてcGMPおよびGLPに準拠した試験サービスを提供するエメリー・ファーマとの戦略的提携を発表した。この提携により、薬物相互作用 (DDI) 試験で使用される主要薬剤であるリファンピンに対し、1-メチル-4-ニトロソピペラジン (MNP) …
Fortrea 與 Emery Pharma 宣佈開展戰略合作，使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗
GlobeNewswire
·
June 24, 2025
達勒姆，北卡羅來納州, June 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的受託研究機構 (CRO) Fortrea (Nasdaq: FTRE)（下稱「公司」）今天宣佈與 Emery Pharma 建立戰略合作關係。Emery Pharma 是一家領先的分析和生物分析受託研究機構，根據現行的《良好生產規範》(cGMP) 和《藥物非臨床研究品質管理規範》(GLP) 提供測試服務。Fortrea 與 Emery Pharma 的戰略合作將為藥物相互作用 (DDI) …
Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원
GlobeNewswire
·
June 24, 2025
노스캐롤라이나주 더럼, June 24, 2025 (GLOBE NEWSWIRE) -- 글로벌 임상시험수탁기관(CRO) Fortrea(나스닥명: FTRE)(이하 “회사”)가 Emery Pharma와 전략적 협력을 발표했다. Emery Pharma는 현행우수제조관리기준(cGMP)과 우수실험실운영기준(GLP)에 맞춰 테스트 서비스를 제공하며 업계를 선도하는 분석 및 생체시료 분석 CRO로, 약물상호작용(DDI) 연구에서 선호되는 리팜핀을 대상으로 로트별 1-메틸 …
Fortrea และ Emery Pharma ประกาศความร่วมมือเชิงกลยุทธ์เพื่อดำเนินการศึกษาวิจัยอันตรกิริยาระหว่างยาที่สอดคล้องกับ FDA โดยใช้ยาไรแฟมปิน (Rifampin…
GlobeNewswire
·
June 24, 2025
เดอร์แฮม, รัฐนอร์ทแคโรไลนา, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“บริษัท”) ซึ่งเป็นองค์กรวิจัยตามสัญญา (Contract Research Organization, CRO) ทางคลินิกชั้นนำระดับโลก ได้ประกาศวันนี้ถึงความร่วมมือเชิงกลยุทธ์กับ Emery Pharma ซึ่งเป็น CRO …
Fortrea 与 Emery Pharma 宣布战略合作以开展符合 FDA 规范的利福平药物相互作用研究
GlobeNewswire
·
June 24, 2025
北卡罗来纳州达勒姆, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea（纳斯达克代码：FTRE，以下简称“公司”）是一家全球领先的合同研究组织（CRO），今日宣布与分析及生物分析领域领先的合同研究组织 Emery Pharma 建立战略合作。Emery Pharma 提供符合现行良好生产规范（cGMP）和良好实验室规范（GLP）的检测服务。该合作将为药物相互作用（DDI）研究中的首选药物利福平快速按批次进行1-甲基-4-亚硝基哌嗪（MNP …
Free Mining Function Fully Upgraded: RIMining Takes You to Mine Bitcoin BTC, Dogecoin DOGE, and Ethereum ETH With Zero Threshold
GlobeNewswire
·
June 24, 2025
Los Angeles, California, June 24, 2025 (GLOBE NEWSWIRE) -- In the new era of digital wealth, who says that mining requires technical skills, mining machines, and high costs? RIMining's newly upgraded "free cloud mining" function is breaking this …
EY US announces Rohit Kapoor of EXL as an Entrepreneur Of The Year® 2025 New York Award winner
GlobeNewswire
·
June 24, 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Ernst …
LeptiCell 2025: This Natural Metabolism Support Supplement Gains Momentum in Weight Management Circles, According to Reports
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In a wellness industry marked by rapid innovation and increasing consumer demand for effective, natural solutions, LeptiCell has emerged as a notable name in the metabolic health space. According to recent …
BioAdaptives Announces National Launch of Pawpa™ Regen
GlobeNewswire
·
June 24, 2025
LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and wellness science, today announces the upcoming national release of Pawpa™ Regen, a proprietary canine supplement that supports …
Nearly Half of Companies Opt to Pay the Ransom, Sophos Report Finds
GlobeNewswire
·
June 24, 2025
OXFORD, United Kingdom, June 24, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today released its sixth annual State of Ransomware report, a vendor-agnostic survey of IT and cybersecurity …
BarxBuddy 2025: This Dog Training Device Gains Momentum Among Pet Owners, According to Reports
GlobeNewswire
·
June 24, 2025
Phoenix, AZ, June 24, 2025 (GLOBE NEWSWIRE) -- In a year marked by increasing interest in at-home pet solutions, the BarxBuddy ultrasonic dog training device has gained renewed momentum among pet owners across the United States. This behavioral training …
Online Crypto Casinos 2025: Recommended by All iGaming Experts
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- At All iGaming, we’ve meticulously tested over 100 crypto casinos to bring you the definitive list of the crypto casinos with no KYC for 2025, available here. Our evaluation focused on real-money …